ADHERIUM LIMITED - Announcements

0.00%

11.0¢

Market Cap $6.037M

Healthcare Medical Devices

Adherium Limited is principally engaged in the development, manufacture and supply of its... Adherium Limited is principally engaged in the development, manufacture and supply of its Smartinhaler digital health technologies, which address sub-optimal medication use and improve health outcomes in chronic disease. It offers a range of smart devices for respiratory medications globally. Its Smartinhaler platform supports asthma and chronic obstructive pulmonary disease (COPD) medication adherence solution. The Bluetooth enabled Smartinhaler medication sensors wrap around patients existing inhalers and automatically send usage data to their smartphone. The Smartinhaler application enables patients and healthcare professionals to track medication adherence, set daily reminders, and discover insights into their medication usage. Its application also enables real-time reporting, monitoring, storing and analysis of inhaler use. The SmartinhalerLive platform uses wireless communications technology to provide real time data collection and reporting from the its Smartinhalers.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

ADR	Notice under section 708A(5)(e) of the Corporations Act		04/04/18	Share
ADR	Appendix 3B (options exercise)		29/03/18	Share
ADR	Adherium receives US FDA 510k OTC clearance	PRICE SENSITIVE	27/03/18	Share
ADR	Response to ASX Query	PRICE SENSITIVE	22/03/18	Share
ADR	Change of Director's Interest Notice (W Hunter)		12/03/18	Share
ADR	Change of Director's Interest Notice (J Mills)		12/03/18	Share
ADR	Change of Director's Interest Notice (B Mogridge)		12/03/18	Share
ADR	Change of Director's Interest Notice (B McHarrie)		12/03/18	Share
ADR	Change of Director's Interest Notice (T Lynch)		12/03/18	Share
ADR	Adherium Directors purchase shares on-market		12/03/18	Share
ADR	Asthma Adherence Management Findings	PRICE SENSITIVE	07/03/18	Share
ADR	Adherium Investor Conference Call Presentation		08/02/18	Share

ADR Notice under section 708A(5)(e) of the Corporations Act
04/04/18		Share
ADR Appendix 3B (options exercise)
29/03/18		Share
ADR Adherium receives US FDA 510k OTC clearance
27/03/18	PRICE SENSITIVE	Share
ADR Response to ASX Query
22/03/18	PRICE SENSITIVE	Share
ADR Change of Director's Interest Notice (W Hunter)
12/03/18		Share
ADR Change of Director's Interest Notice (J Mills)
12/03/18		Share
ADR Change of Director's Interest Notice (B Mogridge)
12/03/18		Share
ADR Change of Director's Interest Notice (B McHarrie)
12/03/18		Share
ADR Change of Director's Interest Notice (T Lynch)
12/03/18		Share
ADR Adherium Directors purchase shares on-market
12/03/18		Share
ADR Asthma Adherence Management Findings
07/03/18	PRICE SENSITIVE	Share
ADR Adherium Investor Conference Call Presentation
08/02/18		Share

REFRESH

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.


Last 11.0¢		Change 0.000(0.00%)		Mkt cap ! $6.037M

Open	High	Low	Volume
11.5¢	11.5¢	11.0¢	72.15K

Buyers (Bids)

Vol.	Price($)
14285	10.5¢

Sellers (Offers)

Price($)	Vol.
11.0¢	54594

Last trade - 14.15pm 16/07/2026 (20 minute delay)

ADR (ASX) Chart